Webdisclosure.com

EDESA BIOTECH (NASDAQ:EDSA)

23/03/2023 21:30

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

16/03/2023 21:10

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

15/03/2023 13:10

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

10/02/2023 15:00

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

01/02/2023 14:15

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

17/01/2023 14:30

Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

20/12/2022 14:30

FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

16/12/2022 15:00

Edesa Biotech Reports Fiscal Year 2022 Results

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

02/12/2022 14:00

Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference

Voir tous les communiqués de Edesa Biotech

EDESA BIOTECH (NASDAQ:EDSA)

03/11/2022 14:00

Edesa Biotech Announces Closing of $3.0 Million Private Placement Priced At-the-Market

Voir tous les communiqués de Edesa Biotech

1
2
3
4
5
6
7
8
9
10